In this special in-person episode filmed straight from the floor at ASCO 2026, Drs. Nicholas Hornstein, Timothy Brown, and Udhayvir Grewal welcome guest Dr. Arvind Dasari (MD Anderson) to discuss why colorectal cancer is officially having its precision medicine moment. From the epidemic of young-onset disease to the frontline tracking of ultra-specific biomarkers, the panel […]
In this episode of The GutOnc Lab, Drs. Nicholas Hornstein, Timothy Brown, and Udhayvir Grewal break down MSI-High GI cancers. A cancer diagnosis is never good news—but this is a setting where tumor biology meaningfully changes what’s possible, with immunotherapy offering real potential for durable responses and even cure. Key discussion points include:MMR vs. MSI: A […]
New updates from the BREAKWATER study continue to transform care for BRAF V600E–mutant metastatic colorectal cancer, showing that moving targeted therapy with encorafenib and cetuximab into the frontline (combined with chemotherapy) more than doubles survival compared with historical approaches. The newly reported FOLFIRI backbone delivers similar efficacy to FOLFOX, offering a neuropathy-sparing alternative for patients […]